Podcasts about Hypoactive sexual desire disorder

Have you ever found yourself not in the mood for sex? What causes this feeling? What do you do when that mood becomes the norm? This week's episode of the Dildo Whisperer takes a look at ways to turn that mood around to help you get back to having a healthy sexual relationship.  Send the us your sex and relationship questions and maybe you will inspire the next episode of The Dildo Whisperer. We have two ways to reach the show. You can call into our show at 844-695-2766 or you can email us at Askthedw@gmail.com. Follow us on social media @dildowhisperer The Dildo Whisperer is produced by DNR Studios. To subscribe to this show and the rest of the DNR Network of shows including the Cookie Jar Podcast visit: www.dnrstudios.com

In recent years, testosterone therapy for women has gained popularity, fueled by self-styled menopause specialists on social media platforms like Facebook and Instagram, as well as celebrity endorsements. The claims associated with this therapy are numerous, ranging from transforming libido to reducing brain fog, improving energy and mood, staving off dementia, enhancing bone strength, and maintaining muscle mass. However, it is essential to scrutinize these claims and evaluate the available scientific studies before considering testosterone therapy for women. OUTLINE: Media DominanceBenefit Claims: fog, mood, energy, dementia, bones, muscle Medical Studies on Claims  Women Exploited? Risks & Side Effects Testosterone Over A Woman's Lifespan  Where does Testosterone Come from? - Conversion Ovary Function - Menopause Reasons to Prescribe Clinical Trial Results 'T' Levels Don't Always Correlate With SymptomsReasons To Promote - Profit FOMO All our links: https://SwingLinks.club SOURCES:Full sources are available on our website...Is the Male Sex Hormone Putting Mid-Life Women at Risk?Testosterone for peri- and postmenopausal womenYen & Jaffe's Reproductive Endocrinology - Physiology, Pathophysiology, and Clinical ManagementAndrogen levels in adult females: changes with age, menopause, and oophorectomyGlobal Consensus Position Statement on the Use of Testosterone Therapy for WomenInternational Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in WomenSupport the showOur Links: Patreon - Want to help support us? - plus you get sexy bonus and behind-the-scenes content Shameless Care - Risk matched, at-home STI testing, and ED Medication SDC - 7-day free trial membership, and join our group YouTube - Like to watch? We need your Likes, and shares, and be sure to subscribe Website - Contact/Call us, sexy products, educational articles, and a FREE Kasidie trial SwingLinks.club - See all our links in one place, including the spicy ones

Theresa Dible discusses weight loss and poor body image this week. It is well documented that poor body image can have an impact on hypoactive sexual desire disorder. She explains that helping patients be more confident about themselves can involve weight loss. She includes all the steps to make that happen, including the use of weight loss meds. She goes over all the anti-obesity meds and how to use them.Show Notes: https://drive.google.com/drive/folders/1yPdIuhfp2ocThAxf12_GhtFMvu5L5abv?usp=sharingContact Information: 614-293-2076Please follow our Facebook page for all podcast updates and relevant information.https://www.facebook.com/profile.php?id=100091994367829Please follow our Instagram page for all podcast updates and relevant information.https://www.instagram.com/sexmedpod/

Amidst the beauty of parenthood, it's common for women to encounter challenges in their intimate lives. The emotional and physical changes that occur after childbirth can affect a woman's perception of herself and her sexuality.We received the question: “Can women become basically asexual after having one or more children?”In the episode, Dr. Rachel Pope is joined by expert Dr. Sheryl Kingsberg to answer it. Dr. Kingsberg is the chief of behavioral medicine at MacDonald Women's Hospital/University Hospitals Cleveland Medical Center and a Professor in Reproductive Biology, Psychiatry, and Urology at Case Western Reserve University. They discuss desire, sex drive, and the definition of Hypoactive Sexual Desire Disorder (HSDD).Featured in this episode: Shifts in desire throughout a person's life The distinction between Asexuality and HSDD Postpartum depression and Psychotherapy Other causes of low desire (This Is Your Brain On Birth Control by Sarah E. Hill)Take the Decreased Sexual Desire Screener (DSDS) Screener here.If you find that the challenges in your sex life persist or are causing significant distress, consider seeking professional help. Sex therapists and counselors specialized in sex can provide valuable guidance and support tailored to your unique situation.Submit your questions on anything and everything women's health-related and we will answer them in one of our episodes.Want more from Our Womanity?Take the Vulva Quiz to see how well you know women's bodies.Looking for practical advice for women in their 60's who want to become sexually active or want to improve their current sex life? Check out Sex in Your Sixties: Who says the fun has to stop? Written by a multidisciplinary group of health professionals who address issues such as pain with sex, low desire for sex, orgasm difficulties, your bladder and sex, same sex partners, vulvar skin conditions, trauma and more.Subscribe to our newsletter here to stay updated and not miss out on new episodes.

In this episode of Causes or Cures, Dr. Eeks chats with Dr. Comninos about Hypoactive Sexual Desire Disorder (HSDD) and his and his team's research on a potential new treatment called Kisspeptin. He will discuss prevalence, diagnosis, symptoms, how the diagnosis may be misdiagnosed as Erectile Dysfunction Disorder, and current treatment approaches to HSDD. In detail, he'll describe what Kisspeptin is and how it might help. He'll also talk about the clinical trials he has conducted involving both men and women diagnosed with HSDD and how well Kisspetin worked in those clinical trials. Dr. Comninos is a Consultant Endocrinologist at Imperial College London where he also leads the Imperial Endocrine Bone Unit. He has authored over 75 clinical and translational publications in reproductive endocrinology, with a focus on reproductive hormones and their influence on both behavior and bones. You can learn more about him here.You can contact Dr. Eeks at bloomingwellness.com.Follow Dr. Eeks on Instagram here.Or Facebook here.Or Twitter.Subcribe to her newsletter here!Support the show

The perfect male contraceptive would be fast acting, 100% effective, temporary and painless — without affecting performance or libido. A new trial appears to have done that.

HERE'S THE THING, SEX IS COMPLICATED AT ANY STAGE OF LIFE.When you throw fluctuating hormones, the stressors ofmidlife, thinning tissue, and the pressure we put on ourselves to perform (in all roles)you can imagine the impact. And yet, no one seems to be talking about it? We'rethrilled to be joined by the Chief Medical Officer of Evernow in this candid conversation.Did you know beforeplay was a thing? We didn't either! Come learn with us.We're also excited to introduce you to a new friend of Hysterical, Evernow, a telehealth platform that is reinventing how women go through menopause. Dr. Leah Millheiser is a Clinical Professor and the Director of the Female Sexual Medicine Program in the Department of Obstetrics and Gynecology at Stanford University Medical Center. She is a NAMS-certified menopause practitioner and her clinical focus is on the treatment of female sexual dysfunction and the care of women in midlife and beyond. Dr. Millheiser holds a B.A. from Columbia University and an M.D. from Northwestern University. After completing her residency in Obstetrics and Gynecology at Stanford University, she became the recipient of the prestigious Women's Reproductive Health Research Scholarship (K12 award) from the NIH. This provided her with the opportunity to do novel research on the specific patterns of brain activation and sexual response among women with Hypoactive Sexual Desire Disorder. Her groundbreaking findings were published in the journal, Neuroscience.

The Women's Health, Wisdom, and... WINE! podcast is a weekly conversation with practitioners, providers, patients & healers about complex reproductive medicine & women's health challenges, the value of an integrative approach to these challenges, many of the women's health topics you're already thinking about & uncomfortable talking about & my personal favorite... WINE!Why is it so hard to have honest conversations about sex?  Hypoactive Sexual Desire Disorder, commonly known as low libido, affects about 1 in 10 women. Conventional medicine usually offers little to no assistance outside of hormonal intervention and often refers women to sex therapy. Is it possible to reconnect with the part of yourself from which you've been disconnected for so long without pharmaceutical intervention? Today we talk about sex from all angles including libido, arousal, pleasure, intimacy, erotic script, desire, and even consent. For most women, sex starts BEFORE the sex starts. About our guest:Renée Yvonne is The Gen SeXologist. She helps passionate Gen Xers and Baby Boomers reignite sexless relationships and navigate health and medical issues that negatively affect sexual performance so they can create an exhilarating sex life and become the fullest expression of who they are sexually. She has been working as a Certified Clinical Sexologist since June 2020. She studied at Sex Coach U and Tantric Institute of Integrated Sexuality. Renée enjoys cooking, swimming, biking, and learning American Sign Language. Resources Mentioned:Come As You Are by Emily NagoskiUltimate Guide to Seduction and Foreplay by Jessica O'Reilly and Marla Renee StewartHalf the Sky: Turning Oppression Into Opportunity for Women WorldwidePleasure MechanicsFear Love Desire worksheetConnect with Renée:PodcastWebsiteFacebookInstagramTwitterLinkedInThe hashtag for the podcast is #nourishyourflourish. You can also find our practice on the following social media outlets:Facebook: The Eudaimonia CenterInstagram: theeudaimoniacenterTwitter: eu_daimonismFor more reproductive medicine and women's health information and other valuable resources, make sure to visit our website at www.laurenawhite.com.Have a question, comment, or want to share your story? Email us at info@laurenawhite.com.Support the show

Today, we will discuss low libido or hypoactive sexual desire disorder in premenopausal women. This is the number one cause for sexual dysfunction in women. We will discuss this with Dr. Kim Fuller, sex therapist, and Dr. Sally McPhedran, obstetrician-gynecologist. We will discuss the biopsychosocial evaluation and the evidence-based therapies for this condition.Articles discussed can be found here https://drive.google.com/drive/folders/1OjnaoIBVGxgthaPbL9Ccn9bDeEOR6O_3Contact Information: Dr. Kim Fuller 216-250-1607 Dr. Sally McPhedran 219-778-1257To comment or inquire about today's discussion go to:ohiosexualhealthcollaborative@gmail.com

On this episode, Dr. Lodhi is joined by her sister, Rafia, as they explore and answer everything you need to know regarding Hypoactive Sexual Desire Disorder. From why and how women get diagnoses with this mental and physical disorder, to how it can be treated, and everything in between, this episode will give you a clear outline of exactly what HSDD is and is not. Disclaimer: Anything discussed on the show should not be taken as official medical advice. If you have any concerns about your health, please speak to your medical provider. If you have any questions about your religion, please ask your friendly neighborhood religious leader. It's the Muslim Sex Podcast because we just happen to be two Muslim women who talk about sex. To learn more about Dr. Sadaf's practice and to become a patient visit DrSadaf.com Follow us on Social Media... Instagram: https://www.instagram.com/drsadafobgyn/ (DrSadafobgyn) TikTok: https://www.tiktok.com/@drsadafobgyn (DrSadafobgyn)

HSDD (Hypoactive Sexual Desire Disorder) is a sexual dysfunction that can lead to a lowered sex drive. Many people may unknowingly dismiss symptoms of this disorder as a side effect of everyday stressors or aging. So, how do you know if it's time to seek professional help? Dr. Michael Krychman and Dr. Sheryl Kingsberg are here to answer all of your questions about HSDD.

Dr. Sheryl Kingsberg is a Clinical Psychologist and Chief of the Division of Behavioral Medicine, Department of Obstetrics & Gynecology, University Hospitals Cleveland Medical Center. She cites four FSDs, female sexual disorders women could experience during their lifetimes. Dr. Kingsberg says there are gender inequities around the treatment of HSDD, Hypoactive Sexual Desire Disorder. She says that 10 percent of women have a loss of sexual interest and women can be distressed by this. The medical community does not take this treatment as seriously as men's sexual function issues especially if women are post-menopausal. Great podcast as we openly discuss these taboo subjects as they relate to women's health and happiness. LeadingShe.com Instagram.com/LeadingShe Facebook.com/LeadingShe https://www.linkedin.com/company/leadingshe/

In today's episode of Women's Health and Beyond, Dr. Ghozland interviews Cindy Eckert, CEO & founder of Sprout Pharmaceuticals, which represents the medication Addyi for low libido. They start their conversation by talking about her journey as an entrepreneur, how she founded and sold the company for $1 billion, and how she essentially got it back for free. They discuss her work to empower women through ‘The Pink Ceiling' company, helping women-owned startups take their businesses to the next level through mentoring, funding, and marketing. Finally, they go in-depth on the medication Addyio itself and how it can help women who suffer from Hypoactive Sexual Desire Disorder. To learn more about Dr. Ghozland's Practice in Los Angeles, visit our website at: https://www.davidghozland.com/ To learn more about Cindy Eckert, visit her on social at: https://www.linkedin.com/in/cindy-eckerthttps://twitter.com/cindypinkceo https://www.instagram.com/cindypinkceo

The Women's Health, Wisdom, and... WINE! podcast is a biweekly conversation with practitioners, providers, patients & healers about complex reproductive medicine & women's health challenges, the value of an integrative approach to these challenges, many of the women's health topics you're already thinking about & uncomfortable talking about & my personal favorite... WINE!Why is it so hard to have honest conversations about sex?  Hypoactive Sexual Desire Disorder, commonly known as low libido, affects about 1 in 10 women. Conventional medicine usually offers little to no assistance outside of hormonal intervention and often refers women to sex therapy. Is it possible to reconnect with the part of yourself from which you've been disconnected for so long without pharmaceutical intervention? Today we talk about sex from all angles including libido, arousal, pleasure, intimacy, erotic script, desire, and even consent. For most women, sex starts BEFORE the sex starts.  About our guest:Renée Yvonne is The Gen SeXologist. She helps passionate Gen Xers and Baby Boomers reignite sexless relationships and navigate health and medical issues that negatively affect sexual performance so they can create an exhilarating sex life and become the fullest expression of who they are sexually. She has been working as a Certified Clinical Sexologist since June 2020. She studied at Sex Coach U and Tantric Institute of Integrated Sexuality. Renée enjoys cooking, swimming, biking, and learning American Sign Language. Resources Mentioned:Come As You Are by Emily NagoskiUltimate Guide to Seduction and Foreplay by Jessica O'Reilly and Marla Renee StewartHalf the Sky: Turning Oppression Into Opportunity for Women WorldwidePleasure MechanicsFear Love Desire worksheetNeethlingshof Chenin BlancConnect with Renee:PodcastFacebookInstagramTwitterLinkedInConnect with VinoBLU® Wine Bar:WebsiteInstagramFacebookTwitterThe hashtag for the podcast is #nourishyourflourish. You can also find our practice on the following social media outlets:Facebook: The Eudaimonia CenterInstagram: theeudaimoniacenterTwitter: eu_daimonismFor more reproductive medicine and women's health information and other valuable resources, make sure to visit our website at www.laurenawhite.com.Have a question, comment, or want to share your story? Email us at info@laurenawhite.com.

What is the role for systemic testosterone in women post menopausal? Global Consensus Position Statement on the Use of Testosterone Therapy for Women https://www.tandfonline.com/doi/full/10.1080/13697137.2019.1637079 International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women https://www.liebertpub.com/doi/10.1089/jwh.2021.29037 --- Send in a voice message: https://anchor.fm/kj-casperson/message

Have you ever wanted to want "ice cream" more? Our friend and entrepreneur, Cindy Eckert, is back to talk more about Hypoactive Sexual Desire Disorder — also known as HSDD. Low sexual desire in women is a medical condition and there is something you can do about it. You can learn more about Cindy and her work at @cindypinkceo on Instagram or by visiting her websites at https://thepinkceiling.com/ and https://addyi.com/.  Get your copy of Everybody Fights here and if you've read it please leave us a review! We hope you get a lot out of this book: http://everybodyfightsbook.com/ Thank you again for your support. It means the world to us.    Join our Facebook family: www.facebook.com/theholdernessfamily Follow the journey on Instagram: @theholdernessfamily Find us on YouTube: www.youtube.com/theholdernessfamily Thank you for being here! Would you consider leaving a review? We also love feedback: holdermesspodcast@gmail.com About the Holderness Family
: Penn, Kim, Lola, and Penn Charles Holderness create original music, parodies, and Vlogs for YouTube and Facebook to poke fun of themselves and celebrate the absurdity in circumstances most families face in their day to day life. They published "Christmas Jammies" in December 2013 and life hasn't been the same. Since then, their popular parodies, "All About That Baste", "Baby Got Class," and original music "Snow Day" have received national news coverage. Penn, the Dad, took a chance and left his job as a news anchor to join his wife Kim, the Mom, at their video production and digital marketing company, Greenroom Communications, LLC. Lola and Penn Charles are always happy, respectful and eat all of their vegetables (that last sentence is a lie).  The Holderness Family Podcast is Edited and Engineered by Max Trujillo of Trujillo Media.

"I worked with women when they’d come in for their annuals and I'd ask them, 'How is it going with your sex life?' Sometimes, they would tense up and wouldn't want to talk about it. Then, I started thinking to myself, 'Wow! Sexual dysfunction is far larger of a problem than I realized when I was in school.'" - Kimberly Mathis Listen in to what the medical professionals have to say about sexual arousal and pain disorders in today's episode of the DYMC Podcast.   Kimberly and Meredith recommended: ISSWSH articles Etiology of Hypoactive Sexual Desire Disorder and Implications for Treatment: Four Case Scenarios by Brooke M. Faught, DNP, WHNP-BC, NCMP, IF, and Susan Kellogg-Spadt, PhD, CRNP, IF, FCST UpToDate (access to medical professionals)   Contact Info: Kimberly Mathis, WHNP-BC, RNC-OB, MSN  Women’s Health Nurse Practitioner (Urogynecology and Reproductive/Infertility Specialist) E-mail: kimberly.b.mathis@gmail.com Meredith McWhirter, MSN, RNC-OB, APRN, NP-C Family Nurse Practitioner (Urology Specialist) E-mail: meredith.mcwhirter@gmail.com Stay in conversation with us on IG: @dearyoungmarriedcouple or on our website: www.dearyoungmarriedcouple.com   Join us for the next Monthly Live Date Night where we dig into some of these topics with you LIVE for 90 minutes this month!

In this fourteenth episode of Sex Ed with DB, Season 4, DB interviews her gorgeous mom, Dr. Rebecca Levy-Gantt, about Hypoactive Sexual Desire Disorder, or HSDD. Dr. Levy-Gantt is a Board Certified ObGyn and a certified menopause practitioner who has been practicing for the last 10 years in Napa, California. Her special interests are menopause management, including hormones and alternative management strategies, as well as vaginal and vulvar pain syndromes. She owns a solo private practice which has been growing for the past 5 years. Read her incredible book "Womb With a View: Tales from the Delivery, Emergency and Operating Rooms" now! --- Sex Ed with DB, Season 4 Team: Creator, Co-Producer, Sound Engineer, and Host: Danielle Bezalel (DB) Co-Producer and Communications Lead: Cathren Cohen Graphic Illustrator: Andrea Forgacs Social Media Intern: Leslie Lopez Website: Alex Morton  --- Sex Ed with DB, Season 4 is Sponsored by: Clone-A-Willy, Aisle, FemmeFunn, Sweet Vibrations, ioba.toys, and Smile Makers Collection --- Love Sex Ed with DB? Email us at Sexedwithdb@gmail.com for comments and questions about what's coming up this season. --- About the podcast: Sex Ed with DB is a feminist podcast bringing you all the sex ed you never got through unique and entertaining storytelling, centering LGBTQ+ folks and people of color. We discuss topics such as intersex rights, abortion, dominatrixes, sex toys, queer sex ed, sex and disabilities, HIV, sex in entertainment, and more. --- Follow Sex Ed with DB on: Website: www.sexedwithdb.com Twitter: @sexedwithdb Instagram: @sexedwithdbpodcast Facebook: @edwithdb TikTok: @sexedwithdb ---

Et oui, c’est la fin de l’année et qui dit fin de l’année dit Gala des grands crus et des piquettes du Pharmascope! Ne ratez donc pas ce 43ème épisode dans lequel Nicolas, Sébastien et Isabelle dévoilent les grands gagnants de célèbres catégories comme Les affaires simples et pas chères mais combien intéressantes ou encore L’étude musicale de l’année ! Les objectifs pour cet épisode sont: Comprendre le rôle de la cigarette électronique en cessation tabagiqueExpliquer les risques et les bénéfices associés à la flibansérineConnaître l’impact de la thérapie par ventilateur en dyspnée en soins palliatifsConnaître l’impact du port d’un masque et de bouchons pour les oreilles sur le sommeil chez les patients hospitalisésIdentifier des mesures pour diminuer la douleur et la peur associées aux injections intrasmusculaires en pédiatrie Ressources pertinentes en lien avec l’épisode Essai randomisé contrôlé comparant la cigarette électronique à la thérapie de remplacement de nicotine en cessation tabagiqueHajek P, Phillips-Waller A, Przulj D, et coll. A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy. N Engl J Med. 2019 Feb 14;380(7):629-637. Article portant sur l’approbation de la flibansérineWoloshin S, Schwartz LM. US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up. JAMA Intern Med. 2016 Apr;176(4):439-42. Revue systématique évaluant l’efficacité et l’innocuité de la flibansérineJaspers L, Feys F, Bramer WM, et coll. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016 Apr;176(4):453-62. Revue systématique évaluant l’efficacité du vinaigre en diabèteCheng LJ, Jiang Y, Wu XV, et coll. A systematic review and meta-analysis: Vinegar consumption on glycaemic control in adults with type 2 diabetes mellitus. J Adv Nurs. 2019 Oct 31. Étude observationnelle évaluant l’association entre la capacité à faire des push-up et le risque cardiovasculaireYang J, Christophi CA, Farioli A, et coll. Association Between Push-up Exercise Capacity and Future Cardiovascular Events Among Active Adult Men. JAMA Netw Open. 2019 Feb 1;2(2):e188341. Étude randomisée contrôlée évaluant l’efficacité d’un ventilateur pour la soulager la dyspnée en soins palliatifsKako J, Morita T, Yamaguchi T, et coll. Fan Therapy Is Effective in Relieving Dyspnea in Patients With Terminally Ill Cancer: A Parallel-Arm, Randomized Controlled Trial. J Pain Symptom Manage. 2018 Oct;56(4):493-500. Étude randomisée contrôlée évaluant l’efficacité du port d’un masque et de bouchons sur le sommeil durant une hospitalisationSweity S, Finlay A, Lees C, et coll. SleepSure: a pilot randomized-controlled trial to assess the effects of eye masks and earplugs on the quality of sleep for patients in hospital. Clin Rehabil. 2019 Feb;33(2):253-261. Étude randomisée contrôlée évaluant l’efficacité de la gomme à mâcher après une césarienneYenigul NN, Aydogan Mathyk B, Aslan Cetin B, et coll. Efficacy of chewing gum for improving bowel function after cesarean sections: a randomized controlled trial. J Matern Fetal Neonatal Med. 2019 Jan 4:1-6. Revue systématique évaluant l’efficacité de la gomme à mâcher après une césarienneCiardulli A, Saccone G, Di Mascio D, et coll. Chewing gum improves postoperative recovery of gastrointestinal function after cesarean delivery: a systematic review and meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2018 Jul;31(14):1924-1932. Étude randomisée contrôlée évaluant l’efficacité de la musicothérapie en pruritDemirtas S, Houssais C, Tanniou J, et coll. Effectiveness of a music intervention on pruritus: an open randomized prospective study. J Eur Acad Dermatol Venereol. 2019 Dec 15. Étude randomisée contrôlée évaluant l’efficacité d’un supplément de vitamine D aux soins intensifsGinde AA, Brower GD, Caterino JM, et coll.

In this episode of #Dictations Dr. Rogers talks about hypoactive sexual desire disorder in women, and a new drug on the market called Vyleesi that treats this condition.

Dr. Alyssa Dweck discusses this condition that many women are uncomfortable talking to their healthcare providers about. Hypoactive sexual desire disorder or HSDD is biological and not a result of issues or unhappiness. It can be handled with the proper care and treatment. Learn more at www.Vyleesi.com. PRODUCT IS ONLY APPROVED FOR USE IN THE U.S. Sponsor: Interview courtesy of AMAG Pharmaceuticals.

On tonight's show, Maureen opens up about the news that syphilis cases are on the rise in Alberta. As well, we talk about forgiveness with a woman who's had to forgive a lot, Erica Harris. We speak to Dr. ??? Gamache about HSDS, or Hypoactive Sexual Desire Disorder. We also sit down with CKNW 980 Vancouver Program Director Larry Gifford to talk about life with Parkinson's Disease, and how it affects intimate life.

On our season 5 finale episode, the hoes shoot the shit about yeast infections, limerence, insecurities, street harassment, hypoactive sexual disorder, cute dates and more. We'll be back in August, enjoy your summer's loves! Bae(s) of The Week: Ajay Holbrook & @aniseliketheseed Hoe(s) of the Week:  Spark Star Academy, Elizabeth, & Juanita and Karima of “We know how to do this (https://podcasts.apple.com/gb/podcast/we-know-how-to-do-this-podcast-for-those-who-know-how/id1440871810) ” podcast plus a shout out to our homegirls Queen and J.  Self Care Tips: How to identify and protect yourself against yeast infections anywhere on and in your body  Date Tip of the Week: Go on a road trip, take a date together, & check out @JayMFKay’s cheap date list  Fuck That (Current Events): There’s a new drug for people with Hypoactive Sexual Desire Disorder     Fuck Me (Our Lives): Akua has evolved past sexual desire and has a fear of fetishizing other queer people while attempting to date folks. Plus she gives thought about disclosing her demisexuality and gives some cautionary hoe tips for summer Rob feels insecure in their relationship and has decided to close it and reminds us that your summer doesn’t have to be a “hot” one and that’s okay. Sam gives a breakdown of the term limerence and explains why you can’t get over that shitty person you used to date. She also gives an aggressive reminder for folks to not harass others this summer and to step in when you see someone getting harassed. Plus she gives us some advice on how to get out there this summer.  Fuck You (Your Lives):  Why are studs uncomfortable with me touching them? And some advice on how to get into the POC BDSM scene in NYC HASHTAGS Use #InnerHoeUprising and #Podin to keep up with this conversation on social media and let others know that you are listening.  RELEVANT LINKS AND NOTES June 29: Queer Global Pride Fundraiser ft. Marsha’s Plate Live:  https://www.instagram.com/p/ByYd1FMn6lt/ July 7: Sex Trivia Sundays: http://sextriviasundaysjuly.eventbrite.com (http://sextriviasundaysjuly.eventbrite.com/) Keep up with IHU Events: https://innerhoeuprising.com/events WEBSITE InnerHoeUprising.com PAY A HOE  http://Paypal.me/innerhoe https://www.patreon.com/InnerHoeUprising  WRITE IN EMAIL ihupodcast@gmail.com (mailto:ihupodcast@gmail.com) SPEAKING GIGS Wanna pay us to speak at your school or conference about sex positivity, black feminism, or the other kinds of topics we discuss on this show?  We’d love to! To book us, send us a line to ihupodcast@gmail.com  MUSIC  Opening: “Queen S%!T” by SheReal https://soundcloud.com/shereal/04-queen-s-t-produced-by  Fuck That: “Keeping it Cool Witchu” Chhoti Maa Fuck Me: "Party on the Weekend" King Kam X DVRKAMBR  Fuck You: "Chandelier" Dramangar End: “Yeah Yeah” Abstract Fish Co ENGINEERING AND EDITING BY  SUMMATIME Sam  SOCIAL MEDIA Join our Facebook Group! “Inner Hoe Uprising CUMmunity” https://bit.ly/2NfFH3A Inner Hoe Uprising| IG & FB: @InnerHoeUprising | Twitter: @InnerHoeUprisin   Akua | IG & Twitter: @heyyakuagirl  Rebecca| IG @thedarkestimeline | Twitter: @rebbyornot |Tumblr: @noneedtomakebeleive Sam | IG & Twitter: @slamridd  Travel IG: @carmensamdiego Rob | Personal IG: @panafrican.bootyscratcher | Art IG: @vanta.blaq | Twitter: @robthe_god  #black #woman #sex #feminist #womanist #Comedy #raunchy #queer

Low sex drive . . . it seems to be a thing that affects many women from time to time. But how do you know when it’s really a problem? We are talking about Hypoactive Sexual Desire Disorder, the medical condition that many women (and even doctors) are not familiar with, and why the Right to Desire Campaign wants to get the word out. We also talk about what couples can do when their appetites for sex don’t match up, and how women who want to boost their sex drive can seek help. In this episode we mention: Jus by Julie  (use that link for 40% off your first order) Maya Chia Supercritical Chia Oil The “Vampire Facial” (microneedling with PRP) at Cosmeticare Suki Exfoliate Cleanser Cupping for low back pain Hypoactive Sexual Desire Disorder Homecoming on Amazon Three books from past guests: Brave Love: Making Space for You to be You by Lisa Leonard Buy the Change You Want to See: Use Your Purchasing Power to Make the World a Better Place by Jane Mosbacher Morris and Wendy Paris Stretched Too Thin: How Working Moms Can Lose the Guilt, Work Smarter, and Thrive by Jessica Turner is $1.99 on Kindle Photo by Becca Tapert on Unsplash Podcast (selfie): Play in new window | Download Subscribe: Apple Podcasts | Android | Google Podcasts | Stitcher | Spotify

Guest: Jacqueline M. Thielen, M.D. (@JacquelineThie5)Host: Darryl S. Chutka, M.D. (@ChutkaMD)Hypoactive sexual desire in females is one component of sexual dysfunction in women. It’s a sensitive topic and one that doesn’t often get discussed in the clinician’s office. What’s the best way to ask about this problem and how do we manage it once we know it exists in our patients? We’ll discuss these issues with a women’s health specialist Dr. Jacqueline Thielen, a Mayo Clinic general internist in the Menopause & Women’s Sexual Health Clinic at Mayo Clinic in Rochester.Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Female sexual difficulties are more common than you think and impact couples inside and outside the bedroom. When sex isn’t easy how do you even begin this conversation with your partner or, for that matter, your healthcare provider? Sociologist, sexologist and relationship expert Dr. Pepper Schwartz joins our Sex+Health podcast for a three-part discussion on the range of female sexual difficulties and offers practical advice and resources for women (and their partners). You’re not alone! Episode One: How do female sexual difficulties (FSD) affect relationships in and out of the bedroom? Episode Two: Concerned your partner is no longer in the mood? It may be more than you think. Episode Three: Diving deeper into the most common female sexual difficulty (FSD), Hypoactive Sexual Desire Disorder (HSDD), and the other types of FSD that may be affecting your relationship.

Host: Michael Krychman, MD Flibanserin was one of the first FDA-approved medications for treatment of Hypoactive Sexual Desire Disorder in pre-menopausal women. But the drug's effectiveness has frequently been called into question, and the known side effects such as fainting, dizziness, and low blood pressure, many of which were found to be exacerbated by alcohol and hormonal contraception, created concerns for clinicians and patients alike. Host Dr. Michael Krychman talks with guest Dr. Lisa Larkin, women’s health internist and Director of the Women's Health Center at the University of Cincinnati College of Medicine, about the “Pink Viagra" pill, concerns around its safety and effectiveness, and the diagnosis and treatment of HDSS.

Interview with Ellen T. M. Laan, PhD, author of Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-Analysis, and Steven Woloshin, MD, MS, author of US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up

Host: Michael Krychman, MD Guest: Sheryl A. Kingsberg, PhD Flibanserin's approval by the FDA for women with hypoactive sexual desire disorder (HSDD), touted by the press as the "Pink Viagra," created an enormous amount of media hype across the nation. But the facts on this drug's mechanism of action, intended benefits, adverse effects, and efficacy borne in clinical trials have gone largely under the radar. Joining Dr. Michael Krychman to discuss the rise of flibanserin and its key takeaways for clinicians is Dr. Sheryl Kingsberg, Chief of the Division of Behavioral Medicine in the Department of OB/GYN and Professor in the Departments of Reproductive Biology and Psychiatry at Case Medical Center University Hospitals in Cleveland, Ohio.

Host: Michael Krychman, MD Guest: Sheryl A. Kingsberg, PhD Flibanserin's approval by the FDA for women with hypoactive sexual desire disorder (HSDD), touted by the press as the "Pink Viagra," created an enormous amount of media hype across the nation. But the facts on this drug's mechanism of action, intended benefits, adverse effects, and efficacy borne in clinical trials have gone largely under the radar. Joining Dr. Michael Krychman to discuss the rise of flibanserin and its key takeaways for clinicians is Dr. Sheryl Kingsberg, Chief of the Division of Behavioral Medicine in the Department of OB/GYN and Professor in the Departments of Reproductive Biology and Psychiatry at Case Medical Center University Hospitals in Cleveland, Ohio.

I'm stunned by the extremes to which a pharmaceutical company will go when attempting to get FDA approval for some new drug. Take a look at the latest offering from privately-held Sprout Pharmaceuticals, who claim they now have a “female Viagra.” Yes, really. It is called Addyi. This drug is potentially dangerous, with some frightening side effects. They include an increased risk of syncope—temporary loss of consciousness—as well as severe low blood sugar, insomnia, dry mouth, fatigue, dizziness, sedation, and anxiety. Manufacturers warn if you decide to use it, not to drink alcohol. I wouldn't touch Addyi with a ten foot pole. Addyi is actually Flibanserin—a failed antidepressant. Unlike Viagra, which is designed to bring more blood flow to male genitals if a man chooses to use it temporarily, Addyi is supposed to be used every day—long-term by women. It claims to enhance a woman's sexual impulses by targeting, not your genitals but your brain. Flibanserin is similar to other selective serotonin reuptake inhibitors (SSRIs) like Prozac. Ironically these drugs are notorious not for increasing libido, but for blunting it. Some time ago, Big Pharma invented a whole new “illness” known as Hypoactive Sexual Desire Disorder, defined as “persistently or recurrently deficient (or absent) sexual fantasies and desire for sexual activity.” Addyi is supposed to treat this. Originally developed by family-owned Boehringer Ingelheim in Germany Flibanserin, after lengthy trails was judged to be ineffective as an antidepressant. Boehringer had submitted this drug to the FDA for approval in 2011. It was refused. Out of 1300 women who took part in trials, 15% dropped out due to unpleasant side effects. The FDA rejected the appeal, saying that whatever the drugs drug's minor benefits might be they could not justify its nasty side effects. So Boehringer sold their invention to Sprout Pharmaceuticals in 2011. Who tried their luck with the FDA in 2013 and also got nowhere. However, Sprout's persistence, massive lobbying and and financial investments amassed more than 60,000 supporting signatures so finally won FDA's approval for the drug in August of 2015. This FDA approval stands next to many other applications which have won FDA approval in the past, showing that, when companies spend enough money, they can, in effect, force the FDA to approve many useless or dangerous drugs. Adriane Fugh-Berman MD, Pharmacology Professor at Georgetown University, describes Addyi as "a mediocre aphrodisiac with scary side-effects.” She adds, “The only thing that's different is a clever, aggressive public relations campaign that Sprout Pharmaceuticals waged successfully.” Meanwhile, the outspoken Dr Mark Sircus makes his own assessment of the situation, which is well worth listening to. Sircus says, “Most doctors and medical associations just do not get that women are different from men sexually. They do not have genitals that function independent of their hearts and minds. The feminine principle is pretty much dead in modern civilization and especially at the FDA, which runs like the SS, a medical Gestapo. The FDA again proves what type of organization it is exposing women in America to the dangers and horrors of pharmaceutical drugs. They are the most unnatural organization in the world poisoning people instead of helping.” Need I say more? If you want to learn about safe natural aphrodisiacs that not only work but are a delight to use, I'll be covering some of my favorites on our next two videocasts. Look forward to seeing you then.

I’m stunned by the extremes to which a pharmaceutical company will go when attempting to get FDA approval for some new drug. Take a look at the latest offering from privately-held Sprout Pharmaceuticals, who claim they now have a “female Viagra.” Yes, really. It is called Addyi. This drug is potentially dangerous, with some frightening side effects. They include an increased risk of syncope—temporary loss of consciousness—as well as severe low blood sugar, insomnia, dry mouth, fatigue, dizziness, sedation, and anxiety. Manufacturers warn if you decide to use it, not to drink alcohol. I wouldn’t touch Addyi with a ten foot pole. a failed antidepressant Addyi is actually Flibanserin—a failed antidepressant. Unlike Viagra, which is designed to bring more blood flow to male genitals if a man chooses to use it temporarily, Addyi is supposed to be used every day—long-term by women. It claims to enhance a woman’s sexual impulses by targeting, not your genitals but your brain. Flibanserin is similar to other selective serotonin reuptake inhibitors (SSRIs) like Prozac. Ironically these drugs are notorious not for increasing libido, but for blunting it. Some time ago, Big Pharma invented a whole new “illness” known as Hypoactive Sexual Desire Disorder, defined as “persistently or recurrently deficient (or absent) sexual fantasies and desire for sexual activity.” Addyi is supposed to treat this. a mediocre aphrodisiac with scary side-effectsOriginally developed by family-owned Boehringer Ingelheim in Germany Flibanserin, after lengthy trails was judged to be ineffective as an antidepressant. Boehringer had submitted this drug to the FDA for approval in 2011. It was refused. Out of 1300 women who took part in trials, 15% dropped out due to unpleasant side effects. The FDA rejected the appeal, saying that whatever the drugs drug’s minor benefits might be they could not justify its nasty side effects. So Boehringer sold their invention to Sprout Pharmaceuticals in 2011. Who tried their luck with the FDA in 2013 and also got nowhere. However, Sprout’s persistence, massive lobbying and and financial investments amassed more than 60,000 supporting signatures so finally won FDA’s approval for the drug in August of 2015. This FDA approval stands next to many other applications which have won FDA approval in the past, showing that, when companies spend enough money, they can, in effect, force the FDA to approve many useless or dangerous drugs. Adriane Fugh-Berman MD, Pharmacology Professor at Georgetown University, describes Addyi as "a mediocre aphrodisiac with scary side-effects.” She adds, “The only thing that’s different is a clever, aggressive public relations campaign that Sprout Pharmaceuticals waged successfully.” FDA - a medical Gestapo Meanwhile, the outspoken Dr Mark Sircus makes his own assessment of the situation, which is well worth listening to. Sircus says, “Most doctors and medical associations just do not get that women are different from men sexually. They do not have genitals that function independent of their hearts and minds. The feminine principle is pretty much dead in modern civilization and especially at the FDA, which runs like the SS, a medical Gestapo. The FDA again proves what type of organization it is exposing women in America to the dangers and horrors of pharmaceutical drugs. They are the most unnatural organization in the world poisoning people instead of helping.” Need I say more? If you want to learn about safe natural aphrodisiacs that not only work but are a delight to use, I’ll be covering some of my favorites on our next two videocasts. Look forward to seeing you then.

I’m stunned by the extremes to which a pharmaceutical company will go when attempting to get FDA approval for some new drug. Take a look at the latest offering from privately-held Sprout Pharmaceuticals, who claim they now have a “female Viagra.” Yes, really. It is called Addyi. This drug is potentially dangerous, with some frightening side effects. They include an increased risk of syncope—temporary loss of consciousness—as well as severe low blood sugar, insomnia, dry mouth, fatigue, dizziness, sedation, and anxiety. Manufacturers warn if you decide to use it, not to drink alcohol. I wouldn’t touch Addyi with a ten foot pole. a failed antidepressant Addyi is actually Flibanserin—a failed antidepressant. Unlike Viagra, which is designed to bring more blood flow to male genitals if a man chooses to use it temporarily, Addyi is supposed to be used every day—long-term by women. It claims to enhance a woman’s sexual impulses by targeting, not your genitals but your brain. Flibanserin is similar to other selective serotonin reuptake inhibitors (SSRIs) like Prozac. Ironically these drugs are notorious not for increasing libido, but for blunting it. Some time ago, Big Pharma invented a whole new “illness” known as Hypoactive Sexual Desire Disorder, defined as “persistently or recurrently deficient (or absent) sexual fantasies and desire for sexual activity.” Addyi is supposed to treat this. a mediocre aphrodisiac with scary side-effectsOriginally developed by family-owned Boehringer Ingelheim in Germany Flibanserin, after lengthy trails was judged to be ineffective as an antidepressant. Boehringer had submitted this drug to the FDA for approval in 2011. It was refused. Out of 1300 women who took part in trials, 15% dropped out due to unpleasant side effects. The FDA rejected the appeal, saying that whatever the drugs drug’s minor benefits might be they could not justify its nasty side effects. So Boehringer sold their invention to Sprout Pharmaceuticals in 2011. Who tried their luck with the FDA in 2013 and also got nowhere. However, Sprout’s persistence, massive lobbying and and financial investments amassed more than 60,000 supporting signatures so finally won FDA’s approval for the drug in August of 2015. This FDA approval stands next to many other applications which have won FDA approval in the past, showing that, when companies spend enough money, they can, in effect, force the FDA to approve many useless or dangerous drugs. Adriane Fugh-Berman MD, Pharmacology Professor at Georgetown University, describes Addyi as "a mediocre aphrodisiac with scary side-effects.” She adds, “The only thing that’s different is a clever, aggressive public relations campaign that Sprout Pharmaceuticals waged successfully.” FDA - a medical Gestapo Meanwhile, the outspoken Dr Mark Sircus makes his own assessment of the situation, which is well worth listening to. Sircus says, “Most doctors and medical associations just do not get that women are different from men sexually. They do not have genitals that function independent of their hearts and minds. The feminine principle is pretty much dead in modern civilization and especially at the FDA, which runs like the SS, a medical Gestapo. The FDA again proves what type of organization it is exposing women in America to the dangers and horrors of pharmaceutical drugs. They are the most unnatural organization in the world poisoning people instead of helping.” Need I say more? If you want to learn about safe natural aphrodisiacs that not only work but are a delight to use, I’ll be covering some of my favorites on our next two videocasts. Look forward to seeing you then.

What is the evidence that taxing sugary drinks will help to tackle obesity? Low libido in women - what is Hypoactive Sexual Desire Disorder and where did the diagnosis originally come from? Is it a label that will liberate millions of women or a construct to market new drugs? Plus Mark visits Europe's largest robotic pharmacy at a brand new hospital in Bristol.

Host: Prathima Setty, MD Guest: Sheryl A. Kingsberg, PhD Hypoactive sexual desire disorder (HSDD) is the most prevalent sexual disorder for women of all ages, but it is also one of the most difficult to address. Clinicians need to understand the implications and address the concerns of their patients. Host Dr. Prathima Setty discusses this topic with Sheryl A. Kingsberg, PhD, Chief, Division of Behavioral Medicine, Department of Obstetrics/Gynecology, University Hospitals Case Medical Center, and Professor, Departments of Reproductive Biology and Psychiatry, Case Western Reserve University, Cleveland, OH. About NAMS The interview was conducted live at The North American Menopause Society (NAMS) 2014 meeting. Founded in 1989, NAMS is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field-including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education-makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit www.menopause.org.

Guest: Jill Warnock, MD, PhD Host: Leslie P. Lundt, MD Is it normal for female patients to “not be in the mood”? How common is libido disturbance in women? Dr. Jill Warnock, an expert in hypoactive sexual desire disorder, discusses with Dr. Leslie Lundt how to evaluate and treat these women.